Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Dr. Marta Sitges
3D echocardiography provides comprehensive information in TAVI, left atrial appendage assessment and soft tissue.
The added value of 3D echocardiography for guiding interventional procedures was reviewed by international experts. First, Dr La Canna from Italy highlighted the advantages of 3D echocardiography, which provides comprehensive evaluation of the annulus, commissures and mapping of the lesions. He nicely showed the newest techniques for percutaneous mitral intervention, such as artificial chordae implantantion and direct ring implantation under 3D echocardiography guidance, with amazing images from their own experience at his institution. Dr Hahn from New York focused her speech on the guidance of TAVI implantation, underscoring the need for 3D imaging, either by MSCT or 3D echocardiography, to assess the annulus. In the cathlab, the usefulness of 3D echo was shown for assessing the symmetry of the deployment of the valve and without a doubt, for the early detection of potential complications during the procedure, including residual paravalvular leaks. With future technical development, intracardiac 3D echo might be the technique of choice in this setting in order to avoid intubation and simplify the procedure even further. The role of 3D echo in assessing left atrial appendage shape and size was addressed by Dr Velazquez Moreno from Mexico, demonstrating the ability of 3D to measure the appendage in all its axes and its utility for guiding Adequate transeptal puncture. Finally, Dr Von Bardeleben from Germany highlighted the excellent soft tissue information provided in real time by echocardiography. He underscored the utility of the simultaneous atrial and ventricular views for crossing the leak, as well as the unique ability of 3D echo to depict the extension of the dehiscence. It was a useful and demostrative review sesión with very illustrative cases from the expert panel!
Guiding Intervention Part II: The added value of 3D echocardiography
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved